Literature DB >> 31585929

Response to: 'Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi et al.

Martin Aringer1, Karen H Costenbader2, Thomas Dörner3, Sindhu R Johnson4.   

Abstract

Entities:  

Keywords:  autoimmune diseases; autoimmunity; systemic lupus erythematosus

Mesh：

Year:  2019        PMID： 31585929     DOI： 10.1136/annrheumdis-2019-216338

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Serum Calprotectin - a NET Product - as a Biomarker of Disease Activity in Patients with Systemic Lupus Erythematosus: A Single-Center Case-Control Study from Poland.

Authors:  Iwona Homa-Mlak; Marcin Mazurek; Aleksandra Majdan; Radosław Mlak; Maria Majdan; Teresa Mełecka-Massalska
Journal:  Med Sci Monit       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.